chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mom states child received several immunizations on 07/06/2005 - noticed rash, itching, upper arms and shoulder Saturday, increased today - denies fever.  Advised give Benadryl.  07/13/2005 Gave Benadryl - rash dried up, no visit.
To ER via ambulance. Got epi pen by paramedic. Given steroids at ER. Discharged on prednisone.
Case number PHEH2013US016100 is an initial spontaneous report received from a pharmacist on 27 JUL 2013. This report refers to an 18-year-old male patient. This patient was only given the MenCYW-135 component of MENVEO (batch number: X11077) intramuscularly without being reconstituted with MenA, on 27 UUL 2013. No adverse event was reported following this administration error (inappropriate preparation of medication).
Mother states child became very sick after vaccination. Signs and symptoms unknown. Child in school 10/9 and 10/13 (Holiday on 10/12).
KNOCKED ON ASS; CANNOT MOVE; ACHY; SHIVERING; RUNNING LIKE 103 FEVER; NAUSEOUS; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included covid 19.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2020, Laboratory data included: Body temperature (NR: not provided) 103 F. On MAR-2021, the subject experienced knocked on bottom. On MAR-2021, the subject experienced cannot move. On MAR-2021, the subject experienced achy. On MAR-2021, the subject experienced shivering. On MAR-2021, the subject experienced running like 103 fever. On MAR-2021, the subject experienced nauseous. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the knocked on ass, cannot move, running like 103 fever, shivering, nauseous and achy was not reported. This report was non-serious.
One week (12/15/21) after receiving my Moderna Booster I started to feel an itch on my left arm and on my shoulder. I didn't think anything of it. On 12/17/21 I started seeing a rash on different areas of my body but thought it was due to holiday stress. 12/18/21 my whole body was covered in a rash. Not constantly - it seems to come and go and is sensitive to the touch. I took Benadryl that night and it stopped the itching. Same thing happened on 12/19/21; rash on my back for no rhyme or reason. On 12/20/21 I started feeling like my throat was getting tight and wondered if this rash was an allergic reaction. I went to Urgent Care. Between 12/17-12/20 I used topical creams, antihistamine sprays and Benadryl to treat the rash.
Pt seen in ER 12/31/2021 by Dr.. Vaccine reaction, initial encounter noted. Pt pregnant 28 and 3/7 weeks, c/o myalgias, fatigue, some degree of headache, afebrile in ER. Had 3rd Covid vaccine today, concern with fetal growth. Husband tested positive Covid 2 days prior. Pt had growth 2 days ago and showed appropriate growth - next appoint next week with OB GYN provider. Tylenol as needed for discomfort, keep appointment next week.
2 days before June he started feeling weakness  Progressive from distal extremity. Seen by ED no dx given. Reffered to neuro but went to another location and diagnosed with Guillain-Barre.
Patient says 10 days after ZOSTAVAX vaccine was administered, she got the shingles. Her MD put her on anti-viral and she is recovering well. She came in pharmacy on 9/16/14 to let us know.
Nausea, chills, headache, body aches. Swollen arm and fatigue
Mom noticed a little spot on top of left thigh this past Friday, believes it is the location of injection of one of his 1 yr shots, stated there was a small bruise there after the injection, it went away and then in the same area a small red dot first appeared on 11/1/19. She didn't think anything about the red dot but then Fever started Sat evening. Fever was gone when waking up Sunday, fever came back Sunday evening at 103.1, and no fever since. Today there is a hard lump under the skin with a red mark that feels hard to the touch. No tenderness. Pt doesn't seem bothered by it. Pt received VVX on upper L thigh on 10/24/19.  This lesion is a little higher than I would have expect for the vaccination, but cannot guarantee where vaccine administration was done. I think fever is likely related to viral URI and not this area of redness, no evid of abcess, rec warm soaks 2x/d, allow him to play in warm tub supervised, call if increased redness or pain, will treat for possible infection in skin with abx. Will complete VAERS form. Phone f/u tomorrow.
Concern for attenuated, vaccine induced varicella infection- diffuse red, itchy rash
Skipped a period. My last period was April 16-20. I had a 2nd Covid Vaccine April 23--didn't have another period until June 9th. Skipped my expected May period altogether. Definitely a result of the vaccine--I've never fully skipped a period before outside of pregnancy (at most up to 2 weeks late). Just wanted to report it as FYI, since it doesn't seem to be being widely reported as something women can be prepared to expect. No need to follow up with me regarding results of any investigation, just adding my data point to the body of evidence.
Pedvax HiB was given by error instead of meningococcal vaccine.  Patient has sore muscle and flu like feeling for a few days, was also tired for 2 hours.  Trial of stimulant which since has been decreased.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. No pertinent medical history was reported. On 05-JUN-2015, the patient was vaccinated with improperly stored ZOSTAVAX (lot # L000450 and expiration date 09-MAR-2016) 0.65 ml once, subcutaneous. No adverse effects reported. No Product Quality Complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
Systemic: Abdominal Pain-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Additional Details: Patient states 4 days after 1st dose of pfizer shot she started having chest pain and stomach upset- i reffered her to her PCP and recommended that gets diagnosed before we do the second shot that is scheduled today on 8/17/21
Approximately 29 hours after my first dose of the Pfizer COVID 19 vaccine I started experiencing right axillary pain that was accompanied by swelling. Lymph node enlargement was not felt. Symptoms are still present at the time of filling this survey out.
Patient had "extremely" sore arm for several days, and flu-like fatigue for 24 hours
Patient received Covid Dose #1 vaccine on 01/25/2021. Patient felt well immediately after receiving vaccine. 30 minutes later, she stood up and started to feel lightheaded, nauseous, and dizzy. She also experienced bilateral leg weakness - legs gave out under when she tried to stand. Feels some subjective shortness of breath. She has experienced similar constellation of symptoms plus palpitations in past related to her tachycardia-induced myopathy. Patient admitted to observation for monitoring same day 1/25/21 at 1618.   Patient did well in observation overnight, no acute events. Patient was discharged at 1035am on 1/26/21.  Patient instructed to follow up with primary care physician in 1-2 weeks.
My left shoulder has had discomfort and limited mobility. This has been going on since time of injection of the Pfizer vaccine.
Breakthrough case admission after 4 vaccines Moderna 2/28/21 lot# 010A21A;  mOdern a3/28/21 Lot# 018B21A;  MOdern a12/29/21 lot# 041J21A;  Moderna 6/29/22 lot# 060A22A
Chest pain, tightness on left side of chest over heart, spasms, racing heart rate when at rest. Elevated blood pressure. Fatigue. Worsens with usual exercise of swimming and biking.  These events started gradually and increased in frequency and intensity.  Most resent one lasted over an hour and went in to ER due to chest pain severe.
"Covid Arm"  redness and itching around the injection site (about 3-4 inches diameter)
Within one hour, red, itchy, inflamed area at injection site. Continued to increase for 3-4 days, then began subsiding. Day 7 it returned. Day 8 the affected area had more than doubled in size, roughly 6x6 inches. This area began dissipating within two days. On 2/1/21, almost two full weeks after my vaccine, I began having pain and severe soreness at the injection site, which continued to increase in the area affected as well as the severity of pain overnight. Today, 14 days after vaccination, my arm is very painful and tingling down to my hand. I have a headache and some overall malaise.
WIFE CALLED 09/17/2022 STATING PT IS EXPERIENCING HIVES AFTER THE SHOT,  PT HAS TAKEN BENADRYL AS THEY HAVE BEFORE FOR HIVES FROM A FLU SHOT PREVISOULY, COUNSELED PT TO GO TO ER IF REACTION GETS WORSE TO THE POINT OF DIFFICULTY BREATHING
not been feeling well at all; Injection site pain; This is a spontaneous report from a contactable consumer (patient). A 79-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot number: EL9262, expiry date unknown), via an unspecified route of administration at the left arm on 29Jan2021 13:15 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported  that he had an injection site pain on 29Jan2021. It was still sore after 3 days and the day afterwards he was not been feeling well at all on 30Jan2021. He was not sure if it has any effect on it, but had a pacemaker put on the right side of his chest in a week before getting the shot so he was not sure if that could affect how he was feeling. The outcome of the event 'injection site pain' was not recovered and the outcome of the event 'not been feeling well at all' was recovering. The vaccination facility type was hospital. The vaccine was not administered at the military facility.
Nausea; tiredness; chills; This is a spontaneous report from a contactable consumer (patient).  A 30-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration at arm left on 26Jan2021 at 09:45 single dose for COVID-19 immunization. The patient medical history included allergy to wasps from an unknown date and unknown if ongoing.  The patient concomitant medication included fluticasone. On 27Jan2021 at 11:00, the patient experienced nausea, tiredness and chills. No therapeutic measures were taken in response to the events. The patient outcome of the events was recovered.
Bloody nose; Have a small bruise on my neck; Have pretty much a constant headache; This is a spontaneous report from a contactable consumer (patient). A 62-years-old female patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: ER8732, Expiration date was not reported), via an unspecified route of administration, administered in left arm on 23Mar2021 at 16:30 hours as dose 1, single (at the age of 62-years-old) for covid-19 immunisation. Medical history included ongoing diabetic and slight high blood pressure, elevated triglycerides, three caesarean section, appendicectomy, both knees have been replaced, shoulder surgery and allergies to statins (from an unknown date and unknown if ongoing). The patient previously took Jardiance, Farxiga and statins and had allergies to Jardiance, Farxiga and statins. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received other medications within 2 weeks of vaccination. Patient was not diagnosed with COVID-19, prior to vaccination. Patient had not been tested for COVID-19, since the vaccination. Patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EW0162, Expiration date was not reported), via an unspecified route of administration, administered in left arm on 14Apr2021 as dose 2, single (at the age of 62-years-old) for covid-19 immunisation. On 30Mar2021 at 05:45 hours (one week to the day of my first vaccine), patient got a bloody nose and stated that she had not had one for several years, so it was alarming. Since then, patient had a bloody nose if not every day, every other day. On unspecified date of 2021, patient had a small bruise on her neck that appeared over the weekend and also had pretty much a constant headache. Patient had received no treatment for all the events. The outcome of all the events was not recovered.
Intense pain in left shoulder beginning several hours after injection. Unable to lift arm more than a few inches for first few days after injection, had to sleep sitting up for first several days to avoid pressure on shoulder, used over-the-counter meds round-the-clock. Saw physician on Dec. 11, who diagnosed significant swelling in the deltoid muscle in left shoulder, recommended gentle exercises, physical therapy if pain continued. Gradual improvement in range of motion but still painful and unable to resume normal activities (tennis, yoga). First appointment with physical therapist scheduled for Dec. 22.
fatigue; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid right, administration date 24Feb2021 08:00 (Lot number: EN6202) as dose 1, single for covid-19 immunisation. Relevant medical history included: "HYPERLIMIDEMIA", start date: 2018 (ongoing). Concomitant medication(s) included: FLUAD QUAD, administration date 11Oct2021; PRAVASTATIN taken for hyperlipidaemia, start date: Jun2019 (ongoing). The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "fatigue"; HEADACHE (non-serious), outcome "unknown", described as "headache". Relevant laboratory tests and procedures are available in the appropriate section.  Follow-up attempts are completed. No further information is expected.
Soreness in upper arm down to elbow. Nothing around injection site. Range of motion is now limited when he reaches his arm behind his back.
fever; body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and MYALGIA (body aches) in a 49-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     The patient's past medical history included Cardiac arrhythmia (past history).    In January 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In January 2023, the patient experienced PYREXIA (fever) and MYALGIA (body aches). At the time of the report, PYREXIA (fever) and MYALGIA (body aches) outcome was unknown.            No concomitant information was reported.  Patient started treatment on an unspecified date in 2021 with Moderna Covid-19 vaccine (elasomeran) dose 1 for Covid-19 immunization. Patient took the Moderna booster last week. No treatment information was reported.   This case was linked to MOD-2023-704801 (Patient Link).
large swollen spot, approximately 2"X3", that is raised, as well as rash type markings; very hot to the touch; arm is very sore/tender; tinging down the arm; chills, headache, "fogginess"
Mom states erythema in shot area started day of injection, worsened through weekend. Presented to Clinic 2/16 with large (about 10 x 11 cm) erythematous area on left upper arm, mildly tender to palpation, no fevers, no induration. Diagnosed with arthus reaction.
This 10 yr old patient was given the 0.2ml of the Pfizer Bivalent 5-11yrs which was Not diluted.  Consequently, he received a dose of 28mcg instead of 20mcg.
Right thigh appears to be swollen compared to the left.  Immunization puncture mark is noted without erythema around the site.  No erythema of the swollen area on the right.  On palpation no acute tenderness is elicited.  Supple and no induration.  Movements of the right lower extremity is normal and the patient is also bearing weight.  Left upper extremity shows a milder swelling compared to the right side.  No tenderness on palpation.  Sometimes keeps the left lower leg bent 90 degrees at the knee.  Right lower extremity was noted to be kept straight most of the time in between it was bent 90 degree as well.   At this point, patient is not showing any signs of inflammation with the tenderness erythema and other signs.  Advised the parent use warm compresses locally.  Can give Tylenol if needed.  The reaction should resolve in the next few days.  Any new symptoms or increase in symptoms parent is advised to call and inform.
This spontaneous report as received from an office worker at a physician's office but not healthcare professional refers to a 10 month old patient. Medical history was not provided. On 12-FEB-2009 the patient was vaccinated with VARIVAX (Merck) dose 1 (route and lot number unknown) on 10 months of age. On 14-DEC-2012 the second dose of VARIVAX (Merck) was administered subcutaneously at physician's office. No adverse effect was reported. No further information was reported. Additional information was requested.
Injection given on 5/14/15. Patient call 5/18/15 with pain in arm. 5/20/15 seen in clinic. Arm painful and swollen.
Headache, Arthralgia, Tachypnea, NauseaVomiting, chest heaviness, fatigue Narrative:
Sore throat; hoarseness; mild dizziness; fatigue; sinus congestion.
Information has been received from a nurse concerning a 15 year old female who on approximately 14-AUG-2007 was vaccinated IM with a 0.5 ml first dose of Gardasil.  Later that evening, the patient's feet started to itch.  The itching spread through her body and the next day she developed a rash all over her body.  The patient went back to the physician's office and the physician recommended BENADRYL.  On an unspecified date, the patient recovered.  Additional information has been requested.
Injection site is hard; Injection site is itchy; Injection site swollen/Injection site is raised/Injection site is twice the size it was; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Injection site is hard), VACCINATION SITE PRURITUS (Injection site is itchy) and VACCINATION SITE SWELLING (Injection site swollen/Injection site is raised/Injection site is twice the size it was) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 27-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 07-Mar-2021, the patient experienced VACCINATION SITE INDURATION (Injection site is hard), VACCINATION SITE PRURITUS (Injection site is itchy) and VACCINATION SITE SWELLING (Injection site swollen/Injection site is raised/Injection site is twice the size it was). At the time of the report, VACCINATION SITE INDURATION (Injection site is hard), VACCINATION SITE PRURITUS (Injection site is itchy) and VACCINATION SITE SWELLING (Injection site swollen/Injection site is raised/Injection site is twice the size it was) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no relevant concomitant medications was reported. No treatment information was provided
received 2 doses in 2019 and a third dose on 2021; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in 2019) and Shingrix (received 2nd dose in 2019).   On 17th November 2021, the patient received the 3rd dose of Shingrix. On 17th November 2021, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were provided as follows: The medical assistant reported that, the patient received 3rd dose of Shingrix, which led to extra dose administered. The reporter consented to follow up.
Cellulitis of the small pox vaccination site. Service member received primary smallpox vaccine on 15 Feb 07. He reports that the next day he had a tattoo placed under the smallpox vaccine site. On 24 Feb 07 while visiting he was evaluated at a medical center for a robust take that extended beyond the parameters of a normal "take". A culture was taken that grew out staph aureaus. Pt was treated with Keflex 500 mg QID Z 5 days. Today he states that he is afebrile, has no LAD, and smallpox site is scabbed over and healing well. He is being deployed tomorrow. No further TX needed. Swelling, erythema.
Bad rash under both arm pits. I'm on day 4 of the rash right now.
This spontaneous report as received from a nurse practitioner refers to a 60 year old female patient. On 07-MAY-2013 the patient was vaccinated with a dose of ZOSTAVAX (0.65 ml,route of administration reported as injection) (lot # J000447, expire date 11-APR-2014). There was no concomitant therapies involved. On an unknown date in 2013, the patient experienced injection site redness (but no rash) after receiving ZOSTAVAX. On an unknown date, in 2013, the patient did not seek medical attention. The outcome of the patient was unknown. The relatedness between ZOSTAVAX and the event was not reported. There was no treatment given for the event. This is one of several reports received from the same source. Additional information has been requested.
Muscle pain in arm, shivering, stomach pain and nausea, all over malaise....
L leg immunization reaction 2 inch erythema surrounding injection site, some hot, bears wt no limping. Tx: ice, Benadryl 1/4 tsp-1/2 tsp q 6 hrs. The follow up states that only DTaP gave reaction.
This case involves child male patient who experienced vomited while receiving INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE [FLUZONE]. It was unknown if the patient had any medical history, concomitant disease, or risk factor. The patient medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included COVID-19 VACCINE for Prophylactic vaccination. On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site Prophylactic vaccination. On 14-Nov-2021, the patient developed a non-serious vomiting (unknown latency) following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE. It was unknown if there were laboratoy data/results available. It was not reported if the patient received any corrective treatment for the event (vomited). At time of reporting, the outcome was resolved on an unknown date for the event vomited. There will be no information available on the batch number for this case.
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions and medical history were not reported. Since 01-DEC-2015 the patients were vaccinated with improperly stored doses of PEDVAXHIB (lot# L014426 with expiration date 08-MAR-2017, strength, dose and route were unknown). The patient's concomitant medication was not reported. No adverse effects have been reported. Additional information has been requested.
pt recvd vax;began to "twitch" p/ awakening from nap;to er;febrile sz & rt otitis media; CT scan of head were Wnl;given po ATB's;
3/2/2022 around 8pm started to complain of feeling itchy around her neck - progressed to hives - woke up at midnight with itchy raised rash.  Have benadryl at 8:30am 3/3/2022 and rash started to fade.